BRCA and beyond: Wider genetic testing of women with epithelial ovarian cancer

被引：0
|
作者：
Flaum, N. [1 ]
van Veen, E. [2 ]
Newman, W. [1 ,3 ]
Crosbie, E. [3 ]
Edmondson, R. [3 ]
Smith, M. [1 ]
Woodward, E. R. [4 ]
Lalloo, F. [4 ]
Evans, G. [4 ]
机构：
[1] Univ Manchester, Div Evolut Infect & Genom, FBMH, Manchester, Lancs, England
[2] Radboud Univ Nijmegen, Med Ctr, Clin Genet, Nijmegen, Netherlands
[3] Univ Manchester, Sch Med Sci, Manchester, Lancs, England
[4] Manchester Royal Infirm Manchester Univ NHS Fdn, Manchester Ctr Genom Med, Manchester, Lancs, England
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.699
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
571P
引用
收藏
页码：S808 / S808
页数：1
相关论文
共 50 条
  • [21] Preventing Future Cancers by Testing Women With Ovarian Cancer for BRCA Mutations
    Kwon, Janice S.
    Daniels, Molly S.
    Sun, Charlotte C.
    Lu, Karen H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (04) : 675 - 682
  • [22] The economic value of knowing BRCA status: BRCA testing for optimizing treatment in recurrent epithelial ovarian cancer
    Oh, Mok
    McBride, Ali
    Bhattacharjee, Sandipan
    Slack, Marion
    Jeter, Joanne
    Abraham, Ivo
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (03) : 317 - 325
  • [23] COST-UTILITY ANALYSIS OF THE GERMLINE BRCA TESTING IN WOMEN WITH EPITHELIAL OVARIAN CANCER WITHOUT FAMILY HISTORY IN SPAIN
    Gonzalez-Dominguez, A.
    Moya, C.
    Simon, S.
    Jimenez-Torres, M.
    Bayo-Lozano, E.
    Sanchez-Heras, A.
    Gonzalez-Martin, A.
    VALUE IN HEALTH, 2018, 21 : S47 - S47
  • [24] GENETIC TESTING IN BREAST OVARIAN-CANCER (BRCA1) FAMILIES
    WATSON, M
    MURDAY, V
    LLOYD, S
    PONDER, B
    AVERILL, D
    EELES, R
    LANCET, 1995, 346 (8974): : 583 - 583
  • [25] Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility
    Wolff, Tracy A.
    Wilson, Jane E.
    AMERICAN FAMILY PHYSICIAN, 2006, 74 (10) : 1759 - 1760
  • [26] Comparison of three testing strategies for germline genetic testing for homologous recombination deficiency mutations in women with epithelial ovarian cancer
    Wilson, Elise
    Stock, Elizabeth
    Huang, Ruizhi
    Buchanan, Tommy
    Kotnik, Emilee
    Mullen, Mary
    Khabele, Dineo
    Kuroki, Lindsay
    Fuh, Katherine
    McCourt, Carolyn
    Thaker, Premal
    Massad, L. Stewart
    Mutch, David
    Powell, Matthew
    Hagemann, Andrea
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S112 - S113
  • [27] Impact of genetic testing in breast/ovarian cancer (BRCA1) families
    Watson, M
    Lloyd, S
    Murday, V
    Ponder, B
    Averill, D
    Eeles, R
    PSYCHO-ONCOLOGY, 1996, 5 (04) : 361 - 361
  • [28] BRCA1 and BRCA2 Genetic Testing in Breast and/or Ovarian Cancer Families in Iran
    Keshavarzi, Fatemeh
    Javadi, Gholam Reza
    Nafissi, Nahid
    Akbari, Mohammad Esmail
    Yassaee, Vahid Reza
    Farzad, Maryam Sharafi
    Zeinali, Sirous
    YAKHTEH, 2010, 12 (03): : 329 - 340
  • [29] BRCA TESTING IN KAZAKHSTANI WOMEN WITH HIGH-GRADE SEROUS OVARIAN CANCER
    Satanova, Alima
    Kaidarova, Dilyara
    Bolatbekova, Raikhan
    Kukubassov, Yerlan
    Madina, Orazgaliyeva
    Ossikbayeva, Saniya
    Kurmanova, Anar
    Aydarov, Askar
    Bertleuov, Orynbassar
    Kaldybekov, Dauren
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A132 - A132
  • [30] Genetic testing for women previously diagnosed with breast/ovarian cancer:: Examining the impact of BRCA1 and BRCA2 mutation searching
    Hallowell, N
    Foster, C
    Ardern-Jones, A
    Eeles, R
    Murday, V
    Watson, M
    GENETIC TESTING, 2002, 6 (02): : 79 - 87
12345